Amicus' Pompe disease therapy joins early access scheme
9th June 2021 Uncategorised 0The MHRA has issued an EAMS scientific opinion opening the door to use of cipaglucosidase alfa with miglustat in eligible patients with Pompe disease More: Amicus' Pompe disease therapy joins early access scheme Source: News
read more